Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Working Capital to Net Assets Ratio
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares working capital to net assets ratio. Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has a Working Capital to Net Assets ratio of 95.4% as of June 2026. Working capital of $9.14 Million (current assets of $12.33 Million minus current liabilities of $3.20 Million) is measured against net assets of $9.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check HKPD tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2026)
Working capital to net assets ratio of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2026. This chart shows how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2023 to 2026. As of June 2026, the ratio stands at 95.4%, reflecting working capital of $9.14 Million against net assets of $9.58 Million USD. See Hong Kong Pharma Digital Technology Hold (HKPD) liquidity interval to measure how many days the company can operate on defensive assets alone.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Working Capital to Net Assets Ratio by Year (2023–2026)
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares working capital to net assets ratio by year from 2023 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2026, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Hong Kong Pharma Digital Technology Hold balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 95.4% | $9.14 Million | $9.58 Million | $12.33 Million | $3.20 Million | ▼ -21.1 pp |
| 2025 | 116.4% | $5.81 Million | $4.99 Million | $8.73 Million | $2.92 Million | ▲ +7.7 pp |
| 2024 | 108.7% | $4.63 Million | $4.25 Million | $7.80 Million | $3.18 Million | ▲ +74.8 pp |
| 2023 | 33.9% | $198.40K | $585.24K | $2.75 Million | $2.55 Million | — |